HealthAugust 12, 2026
adagrasib
AD-uh-gra-sib
Definition
A targeted drug used in combination studies to treat certain cancers with specific genetic mutations, such as KRAS G12C.
Etymology
Like many modern pharmaceutical names, adagrasib follows a naming convention developed by the United States Adopted Names (USAN) Council, where the suffix '-asib' denotes it is a kinase inhibitor.
In the news
In the article, the drug adagrasib is cited in combination studies with the company's own asset, darlifarnib, as part of its strategy to develop differentiated precision oncology platforms.
Earnings call transcript: Kura Oncology tops Q2 2026 estimates as launch gains
Read the full article ↗Investing.com